AVITA Medical Inc

AVITA Medical Inc

RCEL

Get informed when a big investor buys or sells

+ Follow
Market Cap$107.57M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
AVITA Medical IncAVITA Medical Inc-29.2-196%--0.1
$8.00

Target Price by Analysts

92.3% upsideAVITA Medical Target Price DetailsTarget Price
$-9.80

Current Fair Value

335.6% downside

Overvalued by 335.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$107.57 Million
Enterprise Value$101.24 Million
Dividend Yield$- (-)
Earnings per Share$-1.74
Beta1.9
Outstanding Shares305,408,720

Return

Return on Equity195.71%ROE
Return on Assets-87.96%
Return on Invested Capital159.35%

Valuation & Multiples

P/E Ratio-29.17P/E Ratio
PEG124.46PEG
Price to Sales-Price to Sales
Price to Book Ratio-4.16Price to Book Ratio
Enterprise Value to Revenue1.4
Enterprise Value to EBIT-4.2
Enterprise Value to Net Income-3
Total Debt to Enterprise0.02
Debt to Equity-0.09Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.35
Average shareholder expectation
Revenue Estimate
$18.30 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-0.32
Average shareholder expectation
Revenue Estimate
$19.90 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 36.88%
Total Calls40,985,800 70201.54%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %165.81% 148.50%
Total Invested$61.57M 270.04%
Investors Holding79 9.00%

ESG Score

No data

About AVITA Medical Inc

Relevant Senate Committees

Finance

Oversees Medicare and Medicaid (CMS); reimbursement codes and pricing decisions determined here are critical to the commercial adoption of AVITA's products.

Appropriations

Controls the specific allocation of funds to agencies like BARDA, the NIH, and the VA, which are major financial drivers and customers for AVITA.

Health, Education, Labor, and Pensions

Directly oversees the FDA, which regulates the approval, labeling, and safety monitoring of all AVITA Medical products.

Judiciary

Oversees patent law and intellectual property rights, which are fundamental to protecting the proprietary technology behind the RECELL System.

Armed Services

AVITA has had significant defense-related partnerships and funding for trauma applications in combat medicine; the NDAA impacts their potential for military contracts.

Veterans' Affairs

The RECELL System is used in VA hospitals for trauma and burn care; committee decisions regarding VA healthcare budgets and procurement directly impact AVITA's revenue.